{{Rsnum
|rsid=11737764
|Gene=NUDT6
|Chromosome=4
|position=122905625
|Orientation=plus
|GMAF=0.2029
|Gene_s=NUDT6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 83.2 | 16.8 | 0.0
| HCB | 86.1 | 13.1 | 0.7
| JPT | 88.5 | 11.5 | 0.0
| YRI | 16.3 | 46.9 | 36.7
| ASW | 35.1 | 49.1 | 15.8
| CHB | 86.1 | 13.1 | 0.7
| CHD | 90.8 | 9.2 | 0.0
| GIH | 56.4 | 34.7 | 8.9
| LWK | 21.8 | 45.5 | 32.7
| MEX | 60.3 | 36.2 | 3.4
| MKK | 23.7 | 51.9 | 24.4
| TSI | 84.3 | 13.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23113306
|Title=Association of FGFR3 and MDM2 Gene Nucleotide Polymorphisms with Bone Tumors
}}

{{PMID Auto
|PMID=19456219
|Title=Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.
|OA=1
}}

{{PMID Auto
|PMID=24640097
|Title=Associations of single nucleotide polymorphisms with malignant and borderline bone tumors
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}